Mydecine Innovations Group, Inc. (MYCOF)

0.18
OTC Markets
Prev Close 0.18
Day Low/High 0.16 / 0.19
52 Wk Low/High 0.03 / 0.89
Exchange OTC Markets
Shares Outstanding 166.52B
Market Cap 29.97M
Div & Yield N.A. (N.A)

Psychedelic companies hoping to capitalize on a surging interest in psilocybin treatments have been limited to one source for research grade psilocybin. Until now.

Investors are anxious to grab the next penny stock that may be poised to jump on the mind-blowing bubble. Here they are.